Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
The Budget 2016 - An investor's perspective - See how Britvic features in the overview by our expert blogger and former Barclays Stockbrokers Director - Read it here - http://www.lse.co.uk/lseBlogs/blogEntry.asp?section=expert&blog=david-harbage-blog&entry=na2bja&full-url=blogs/expert/david-harbage-blog/na2bja/
looks like a well executed cost cutting program - http://www.risersandfallers.com/2015/11/25/britvic-cuts-costs-and-increases-profit-margins/
Nov 24, 2015 at 05:30 Britvic ripe for rerating Drinks retailer Britvic (BVIC) has lagged the market and its shares are now the cheapest in the staples sector, providing a buying opportunity. Barclays analyst Simon Hales reiterated his ‘overweight’ recommendation and increased the target price from 780p to 825p. The shares dipped 4p to 723.5p yesterday. ‘Britvic has lagged that staples sector year-to-date and now trades on a current year 2016 estimates price/earnings ratio of just 14.6x – a -33% and -3% discount to the sector and market respectively,’ he said. ‘Given its two-year compounded total shareholder return of 13.7%, the shares are now the cheapest in staples on a price/earnings to growth basis. With full year 2015 estimates on track and comps easing, the stock is ripe for re-rating. ‘Moreover, our analysis suggests full year 2016 estimates may prove conservative.’
Happy Days !!!
Sorry, the forum won't allow my links. Or edits... It can be found on seeking alpha dot com
Hi, for those who are interested; a while back I wrote an extensive article on Britvic published here: http://bit.ly/timberwolfequity-bvic
Nice stead rise over the past month. Happy to hold until £8 a share!
Britvic shares jump on profit target: Britvic, the Owner of Robinson’s fruit juice, said it was still on target to hit profit expectations despite falling sales and a loss of market share in the U.K. ‘ss update sent the shares almost 6% higher. The FTSE 250-listed soft drink maker is operating in an extremely difficult U.K. drinks market. The big supermarkets are cutting prices to win back customers from the discounters and soft drinks are just one of the many battle grounds. Britvic said that it is losing market share in the squash category and this is most likely supermarket own brands eating its lunch. Britvic has suffered a setback attempting to expand into the U.S. market. The company reported a fall in sales of 3.6% to £10.7 million to the end of December and said new manufacturing processes in the U.S. meant it had to deliver less of the concentrated juice used to make its products. The drinks company said it remains on target to achieve earnings before interest and tax of between £164 million to £173 million for the year to September. This is due to a sharp focus on costs and Simon Litherland, Chief Executive, is looking to achieve £30 million of annual cost savings by 2016. The shares have been weak during the past 12 months having peaked at 777.5p in February last year as investor’s feared for falling sales and price competition in U.K. soft drinks. The shares are now trading on 15.7 times 2014 forecast earnings, falling to 14.2 times next year. The company remains at risk from increased regulation such as a sugar tax or a washout summer. However, these are impossible to predict, and Britvic has proven its long-term quality. The shares also have a 3.5% prospective dividend yield on offer, and that is set to increase by 10% during the next two years, so the shares remain a solid hold. Britvic at 688.5p+42.5p. Questor Says “Hold”.
fastarm, You should find this page useful....
Anyone got the ex d date please? Cheers.
Brokers Views..... Britvic PLC SUMMARY CHARTS DIRECTOR DEALINGS FORECASTS WIRES Page is currently unavailable 2014 2015 Date Rec Pre-tax (£) EPS (p) DPS (p) Pre-tax (£) EPS (p) DPS (p) SG Securities 21-10-14 BUY 41.23 20.30 48.21 23.75 Shore Capital 17-10-14 BUY 129.50 40.80 19.60 147.90 47.10 20.80 Westhouse Securities 25-09-14 BUY Mirabaud Securities 15-09-14 ADD 130.00 41.26 20.08 150.00 47.23 23.08
BVIC BRITVIC after a good trading update look to have plenty of momentum behind them. I fully expect broker updates perhaps upgrades over the next few days. http://content.screencast.com/users/thomaser/folders/Default/media/8e2fd89b-906d-4ebe-b27c-3cb48e507605/bvic%2012.jpg" <b>Britvic FY to be slightly ahead of guidance</b> StockMarketWire.com Soft drinks group Britvic's full year revenues increased by 2.4%, with both volume and price growth. And it says the strategic cost initiatives were successfully implemented with a slightly higher in-year benefit than anticipated. As a result the group now expects that EBIT for the year to 28 September will be marginally ahead of the top end of its previous guidance range of £148m to £156m and well ahead of last year. Chief executive Simon Litherland said: "We have delivered a strong performance despite the poorer summer weather and the continued challenging trading environment. We now expect operating profit marginally ahead of the top end of the guidance range we outlined at the start of the year. "Full year revenue grew 2.4% and the accelerated delivery of our strategic cost initiatives pulled the in-year savings ahead of our original plan. I am especially pleased that we have delivered a strong set of results, with profits well ahead of last year, at the same time as undertaking a significant internal change programme. We are now set up to take advantage of the growth opportunities ahead of us. "We anticipate that the prevailing challenging market conditions will continue for some time. Nevertheless, we look forward with confidence to further earnings growth in 2015, as we realise the full year benefit of the cost initiatives and execute our extensive innovation and marketing plans for the year. We will share more details of this in our preliminary results in November."
Broker Forecasts for BVIC all well above present SP which was brought down with the general market over the last few weeks....... BRITVIC BROKER VIEWS Date Broker Recommendation Price Old target price New target price Notes 25 Jul Numis Hold 692.25 765.00 765.00 Reiterates 24 Jul Investec Hold 692.25 716.00 725.00 Retains 21 Jul Nomura Buy 692.25 - - Reiterates 18 Jul JP Morgan Cazenove Neutral 692.25 730.00 730.00 Retains 11 Jul Goldman Sachs Neutral 692.25 764.00 778.00 Reiterates
Gone long here. looks like a SP recovery is on the way. https://pbs.twimg.com/media/BuwiE7oCMAEdYOr.jpg
large lump dumped, that's 3 days in a row.
a look in again to see yet another rise. Do we have any thoughts here on the debt side of things, clearly the sp is responding well to the revenue increase but we still have only around 10% of those funds as net profit. Would be great to get some others opinions as no doubt the 52 week high will go again tom.
the rise with this one! After the results what do we see as a correct value? The brokers appear to have a huge range between them.
Lost for words with this one, No news since the merger collapse yet we see historical highs over and over again! Results due next month will be very important for future direction.
Their results were out today - good summer sales, hence crossover rise here in anticipation of the same.
52 week high gone, almost everyday other day now for the past month or so. Not stopped booming since the merger collapse!
Just doesn't stop with this one. What an uptrend. Summer will no doubt have been kind to the sales figures. More to come or already priced in?
Decent enough set of results - revenues up 4% and on track at the upper end of market expectations for the full year.. Market perhaps expecting a bit more? US and Indian fruit shoot roll out still to show through over the next year or so, so hopefully decent growth to come in the near future.
Q3 IMS due on 25 July - one would think that all this hot weather will be good for Britvic profits ...